On November 4, 3SBIO recorded an Intraday Rise of 5.1% in Regular Trading, with the stock trading at HK$14.65 and turnover reaching HK$250 million.

The latest disclosed catalyst was the company’s monthly securities return, which showed that 3SBIO repurchased 6.3375 million shares between October 8 and October 14 and held them as treasury shares, a signal often read as management support for valuation.

The filing detailed five on-market buybacks executed at prices ranging from HK$14.40 to HK$15.59 per share. During the same period, stock options were exercised for 660,000 new shares at HK$7.62 each, generating total proceeds of HK$5.0292 million. By the end of October, issued shares excluding treasury stock stood at about 2.514 billion, while treasury shares totaled 25.1135 million; the company also confirmed compliance with public float requirements.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)